Prof. John Camm discusses dronedarone (Multaq) and vernakalant, new antiarrhythmic drugs for atrial fibrillation -- Video
Posted Jan 23 2010 4:21pm
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it.
See the video: Interview with Professor John Camm at Boston Atrial Fibrillation Symposium 2010